Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double blind, double dummy, comparative, active-controlled
trial designed to assess the analgesic activity and safety of intravenous doses of parecoxib
40 mg relative to intravenous doses of ketoprofen 100 mg for the treatment of renal colic in
outpatients presenting at emergency room settings. This trial is designed to show
non-inferiority of parecoxib related to ketoprofen.